Federica Ferrario: What is Increasingly Becoming the 5-Fraction Revolution in the Postoperative Setting
Federica Ferrario, Radiation Oncologist at the University of Milan, shared a post on LinkedIn about recent paper she and colleagues co-authored:
“Proud to share the mid-term results of the POPART trial, now published and available online on Radiotherapy and Oncology!
This study represents the core of my residency thesis, but above all, it’s a project I truly believe in — thanks to the vision and passion of Prof. Stefano Arcangeli who involved me from the beginning and inspired me to embrace it fully. Deeply grateful for the trust and for giving me this incredible opportunity.
Alongside international trials like SCIMITAR (Amar Kishan) and SHORTER (Himanshu Nagar, MD MS, POPART) adds an important piece to what’s increasingly becoming the 5-fraction revolution in the post-op setting.”
Title: Predictors of toxicities and oncological outcomes following postoperative ablative radiotherapy (POPART) for biochemical recurrence
Authors: Federica Ferrario, Ciro Franzese, Suela Vukcaj, Valeria Faccenda, Raffaella Lucchini, Chiara Chissotti, Riccardo Ray Colciago, Enrico Raggi, Roberta Muni, Luciana Di Cristina, Lorenzo De Sanctis, Giulia Rossano, Stefano Andreoli, Sara Parabicoli, Gian Luca Poli, Margherita Crespi, Denis Panizza, Marco Roscigno, Luigi Filippo Da Pozzo, Alessandro Magli, Stefano Arcangeli
Read The Full Article at Radiotherapy and Oncology.
More Posts Featuring Radiotherapy.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023